About this trial
To explore the effectiveness of EMDR therapy treatment in reducing symptoms of chemotherapy-induced conditioned nausea and vomiting in (former) patients with cancer.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Previously pathologically confirmed diagnosis of cancer
Previously treated with systemic cancer therapy
Persistent complaints (more than 2 months) of conditioned nausea and/or vomiting
Able to understand spoken and written Dutch
Disqualifiers
Ongoing psychiatric treatment
EMDR therapy contraindications (dissociative disorders, personality disorders or severe somatic disorders (e.g. cardiac arrhythmias))
Complex type 2 trauma
Known with recent conditions / non-anti-cancer medication which can elicit nausea (e.g. pregnancy or alcohol abuses)
Trial design
Single group
Treatments tested in this trial
EMDR therapy
Other interventionIn this study, EMDR therapy will be performed by psychologists of the UMCG who are trained in EMDR therapy and who have experience with patients with somatic diseases. In the EMDR therapy protocol, the patient is guided through eight phases which incorporate dual focus of attention and alternating bilateral visual, auditory, and/or tactile stimulation (see supplement for protocol). The number of sessions varies per patient (1-3 sessions), depending on the desensitization of the conditioned stimuli. The sessions will last 60-90 minutes.
Treatment groups
Trial outcomes
Primary outcomes
Degree of conditioned nausea and vomiting
Degree of conditioned nausea and vomiting after exposure to conditioned stimuli using the nausea profile questionnaire measured using the nausea profile questionnaire (9-point Likert scale, higher scores = worse outcome)
Secondary outcomes
Impact on QoL of conditioned nausea and vomiting
Impact on QoL of conditioned nausea and vomiting using Functional Living Index- Emesis (FLIE) questionnaire (7-point Likert scale, higher scores = better/worse outcome, depending on the question)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.